03/04/2015 - 6:28pm

There was a $1.1 billion gain in OTC sales between 2013 and 2014, according to data culled from IRI, some $500 million of which can be attributed to an increase in sales across all cough-cold/allergy/sinus products and an approximate $300 million to a rise in digestive sales.

02/27/2015 - 5:25pm

Epic Pharma on Friday launched two generics: a schedule II pain reliever and a calcium channel blocker. 

02/27/2015 - 11:24am

Camber Pharmaceuticals' latest generic drug launch is used to treat pulmonary hypertension.

02/26/2015 - 1:53pm

Sanofi expands its portfolio of insulin therapy products with the introduction of the once-daily, long-acting Toujeo. 

02/26/2015 - 1:03pm

Greenstone, a subsidiary of Pfizer, announced the introduction of trandolapril/verapamil hydrochloride extended-release tablets to its line of generic pharmaceutical products. 

 

02/26/2015 - 12:43pm

The fixed-combination drug Avycaz was granted priority review by the Food and Drug Administration. 

02/24/2015 - 3:41pm

Lupin will bring to market a generic version of Lumigan solution, the company announced. 

02/17/2015 - 10:12am

The Food and Drug Administration has approved Lenvima (lenvatinib) for the treatment of differentiated thyroid cancer. 

02/17/2015 - 9:54am

Teva Pharmaceuticals on Tuesday announced the launch of generic versions of Lovenox (enoxaparin sodium injection) as well as generic Zyvox (linezolid) injection.